An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway
Frontiers in Pharmacology · 06.01.2025 · 15
DOI: 10.3389/fphar.2024.1513422 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.01.2025. Verfasst von Pratibha Pandey und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research Impact and Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Nuclear factor-κB (NF-κB) cell signaling pathway is essential for the progression and development of numerous human disorders, including cancer. NF-κB signaling pathway regulates a wide range of physiological processes, such as cell survival, growth, and migration. Deregulated NF-kB signaling resulted in unregulated cell proliferation, viability, movement, and invasion, thus promoting tumor development. Recent findings have increasingly shown that plant derived phytochemicals that inhibit NF-κB signaling have the potential to be employed in cancer therapeutics. Flavonoids are a group of polyphenolic natural compounds present in various plants and their fruits, vegetables, and leaves. These compounds have numerous medicinal properties owing to their antioxidant, anti-inflammatory, antiviral, and antitumor characteristics. The main mechanism by which these flavonoids exhibit their anticancer potential is via potent antioxidative and immunomodulatory actions. Current research reports have demonstrated that these flavonoids exhibited their anticancer effects via suppressing the NF-κB signaling. Based on these facts, we have comprehensively outlined the cancer promoting role of NF-κB pathway in various processes including tumor progression, drug resistance, angiogenesis and metastasis. In addition to these, we also summarize the anticancer potential of flavonoids by specifically targeting the NF-κB pathway in various types of cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Research Impact and Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
- KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
- School of Applied and Life Sciences, Uttaranchal University, Dehradun, India.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Pandey, P., Lakhanpal, S., Mahmood, D., Kang, H. N., Kim, B., Kang, S., Choi, J., Choi, M., Pandey, S., Bhat, M., Sharma, S., Khan, F., Park, M. N., & Kim, B. (2025). An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1513422
Vancouver
Pandey P, Lakhanpal S, Mahmood D, Kang HN, Kim B, Kang S, et al. An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway. Frontiers in Pharmacology. 2025;15. doi:10.3389/fphar.2024.1513422
BibTeX
@article{Pandey2025,
author = {Pandey, Pratibha and Lakhanpal, Sorabh and Mahmood, Danish and Kang, Han Na and Kim, Byunggyu and Kang, Sojin and Choi, Jinwon and Choi, Min and Pandey, Shivam and Bhat, Mahakshit and Sharma, Shilpa and Khan, Fahad and Park, Moon Nyeo and Kim, Bonglee},
title = {An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {15},
doi = {10.3389/fphar.2024.1513422}
}
EUVIMED